HEXO Corp (HEXO)
0.71
0.00 (0.00%)
USD |
NASDAQ |
Jun 30, 16:00
HEXO SG&A Expense (Quarterly): 10.22M for April 30, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
April 30, 2023 | 10.22M |
January 31, 2023 | 9.983M |
October 31, 2022 | 11.67M |
July 31, 2022 | 14.25M |
April 30, 2022 | 30.30M |
January 31, 2022 | 25.99M |
October 31, 2021 | 25.87M |
July 31, 2021 | 19.24M |
April 30, 2021 | 15.87M |
January 31, 2021 | 15.31M |
October 31, 2020 | 12.80M |
July 31, 2020 | 13.43M |
April 30, 2020 | 14.22M |
January 31, 2020 | 17.27M |
October 31, 2019 | 22.93M |
July 31, 2019 | 31.69M |
April 30, 2019 | 17.85M |
January 31, 2019 | 13.48M |
Date | Value |
---|---|
October 31, 2018 | 16.35M |
July 31, 2018 | 7.696M |
April 30, 2018 | 3.858M |
January 31, 2018 | 4.028M |
October 31, 2017 | 2.076M |
July 31, 2017 | 1.679M |
April 30, 2017 | 1.639M |
January 31, 2017 | 1.173M |
December 31, 2016 | 0.0209M |
September 30, 2016 | 0.0106M |
June 30, 2016 | 0.0098M |
March 31, 2016 | 0.0304M |
December 31, 2015 | 0.0074M |
September 30, 2015 | 0.0364M |
June 30, 2015 | 0.0021M |
March 31, 2015 | 0.0214M |
December 31, 2014 | 0.1221M |
June 30, 2014 | 0.0056M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
9.983M
Minimum
Jan 2023
31.69M
Maximum
Jul 2019
17.83M
Average
15.87M
Median
Apr 2021
SG&A Expense (Quarterly) Benchmarks
Acasti Pharma Inc | 1.871M |
Aurinia Pharmaceuticals Inc | 47.08M |
Edesa Biotech Inc | 1.039M |
Lexaria Bioscience Corp | 0.8233M |
Liminal Biosciences Inc | 3.550M |